Substance / Medication

Fosfomycin

Overview

Active Ingredient
fosfomycin
RxNorm CUI
4550

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Fosfomycin for the treatment of patients with bacterial prostatitis: a systematic review.
Kontogiannis Dimitrios S, Agoranou Maria Eleni, Dimitriadis Fotios et al. · Eur J Clin Microbiol Infect Dis · 2025
PMID: 40410452Meta-Analysis
[Fosfomycin as antibiotic prophylaxis in men undergoing transrectal prostate biopsy: a systematic review of the literature].
Bernikov A N, Govorov A V, Bagateliya Z A · Urologiia · 2024
PMID: 40377567Meta-Analysis
Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review.
Fonnes Siv, Fonnes Masja Klindt, Holzknecht Barbara Juliane et al. · Drug Res (Stuttg) · 2024
PMID: 38016655Meta-Analysis
Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
Gu Hui Mo, Gu Jin Seok, Chung Ho Seok et al. · Medicina (Kaunas) · 2023
PMID: 37241143Meta-AnalysisFull text (PMC)
Rediscovering the value of fosfomycin trometamol in the era of antimicrobial resistance: A systematic review and expert opinion.
Cai Tommaso, Novelli Andrea, Tascini Carlo et al. · Int J Antimicrob Agents · 2023
PMID: 37748624Meta-Analysis
Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies.
Antonello Roberta Maria, Di Bella Stefano, Maraolo Alberto Enrico et al. · Eur J Clin Microbiol Infect Dis · 2021
PMID: 33604721Meta-AnalysisFull text (PMC)
Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature.
Grabein B, Graninger W, Rodríguez Baño J et al. · Clin Microbiol Infect · 2017
PMID: 27956267Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fosfomycin (substance)
SNOMED CT
372534005
UMLS CUI
C0016610
RxNorm CUI
4550

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.